LKKTET and/or LKKTNT peptide compositions and methods

Details for Australian Patent Application No. 2006261157 (hide)

Owner Regenerx Biopharmaceuticals, Inc. Universitaet Erlangen-Nuernberg

Inventors Sosne, Gabriel; Hannappel, Ewald; Goldstein, Allan L.; Crockford, David

Agent Wrays

Pub. Number AU-A-2006261157

PCT Pub. Number WO2006/138709

Priority 60/776,947 28.02.06 US; 60/691,261 17.06.05 US

Filing date 19 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138709 Priority application(s): WO2006/138709

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261162-Naphthyridine compounds

2006261156-LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized